Exciting new discoveries in neurodegenerative research such as Parkinson’s disease and Dementia has accelerated over the past decade as we continue to unfold and target the underlying mechanisms behind these diseases. These molecular targets help scientists predict the risk of developing the disease as well as help identify models to create novel therapies that will slow down and ultimately halt disease progression.
At the Centre for Brain Health (CBH)/Centre for Applied Neurogenetics (CAN) our research is a global effort and one that begins with you, the patient, your family members, caregivers, and friends. Without your research participation, no funding or other resources can provide us with the crucial tools and direction needed to help identify and test novel therapies.
We are extremely grateful for the research participants who have contributed their time to support valuable clinical research around the world. However, with new research developments in neurodegeneration, the need for an increase in the number of research participants is critical now more than ever to help provide more efficient and accurate research findings.
To help facilitate our research efforts, CBH/CAN has set up national and international collaborations with neurologists, neuroscientists, multi-national Pharmaceutical companies, Federal governments, Foundations and philanthropists to inform and share resources to help fast-track discovery.